August 24, 2026 Building a Stronger Path to Therapies for Hereditary Spastic Paraplegia and Primary Lateral Sclerosis For more than 20 years, the Spastic Paraplegia Foundation (SPF) has worked toward a future with better...
July 29, 2026 eCOA Consortium and PCE Consortium Webinar Recording: Event Driven eDiaries At C-Path’s 2026 Clinical Outcome Assessment Program Annual Meeting, attendees heard a brief overview of...
July 9, 2026 Wendy Ruyle Learned That Groundbreaking Science Alone Is Not Enough Early in her career, Wendy Ruyle worked as a study coordinator on clinical trials, a role that put her in direct contact with...
May 13, 2026 Electroencephalography during acute painful procedures in neonates: a scoping review Although electroencephalography (EEG) is used to assess neonatal pain in research settings, EEG assessments...
March 31, 2026 Rare/Orphan and Pediatric Disease Programs: Quarterly Newsletter March 2026 Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...
March 31, 2026 C-Path Newsletter Q1 2026: Momentum in Motion As we close the first quarter of the year, we are energized by the opportunities ahead to further strengthen collaboration...
March 27, 2026 C-Path’s Biomarker Data Repository March 2026 Newsletter March is National Kidney Month, making it an ideal time to highlight the progress and collaborations helping advance kidney health
February 6, 2026 Use of AI within COA linguistic validation and eCOA migration processes: analysis and good practice recommendations While there has been much discussion around the use of Artificial Intelligence (AI) for multilingual translations in other...
December 12, 2025 Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease Autosomal dominant polycystic kidney disease (ADPKD) is the most...
April 16, 2026-April 17, 2026 2026 Clinical Outcome Assessment Program Annual Meeting C-Path's hosted its 2026 Clinical Outcome Assessment (COA) Program Annual Meeting in April at the Washington...
